首页 | 本学科首页   官方微博 | 高级检索  
     

用肝细胞生长因子治疗25例重症肝炎的临床观察
引用本文:李怀斌 蒋迪成 等. 用肝细胞生长因子治疗25例重症肝炎的临床观察[J]. 胃肠病学和肝病学杂志, 1994, 3(1): 55-57
作者姓名:李怀斌 蒋迪成 等
作者单位:河南省人民医院内科
摘    要:
本文用肝细胞生长因子(HSS)加综合治疗方法对25例重症肝炎患者进行了治疗,并对20例重症肝炎病人仅用综合疗法进行对照观察。结果提示:经2个疗程治疗后,治疗组血清转氨酶,胆红素及凝血酶原时间好转例数及恢复正常例数均明显高于对照组(P<0.05)。但在两个疗程时间内,其白,球蛋白比例改善例数在二组间未见有差异(P>0.05)。对照分析还显示,治疗组病人的总体治疗有效率(100%)明显高于对照组(45%)(P<0.05)。提示肝细胞生长因子治疗重症肝炎病人有较好疗效,是一种较好的治疗药物。

关 键 词:重症 病毒性肝炎 肝细胞生长因子 慢性肝病

A Clinical Study by Using Hepatic Stimulate Substance in the Treatment of Hepatic Failure Patients
Li Hui-bin, Jiang Di-cheng, Li Xiu-ling et al. A Clinical Study by Using Hepatic Stimulate Substance in the Treatment of Hepatic Failure Patients[J]. Chinese Journal of Gastroenterology and Hepatology, 1994, 3(1): 55-57
Authors:Li Hui-bin   Jiang Di-cheng   Li Xiu-ling et al
Abstract:
We treated 25 cases acute and chronic hepatic failure patients with hepatic stimulate substance (HSS)plus comprehensive therapy, a control group of 20 cases hepatic failure patients was only treated by comprehensive therapy, the results showed that after 2periodic times of treatments much more patients in the treatment group showed. improvement in serum ALT, BI, PT than in the control group(P<0.05),yet as to the ratio of Albumin and globulin, there was not significant difference between the two groups(P>0.05),Control analysis also suggest that the total improvement in the treatment group(100%)is also significantly higher than that of control group , these results indicated that in the treatment of hepatic failure patients, the HSS plus comprehensive therapy could be a good strategy to the acute and chronic hepatic failure patients.
Keywords:acute hepatic failure chronic hepatic failure hepatic stimulate substance(HSS)
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号